{"SPADE_N_00147": {"Clinical Information": [], "Patent Information": [{"Patent No": "US 2023/0416797 A1", "Patent Link": "http://www.lens.org/lens/patent/US_2023_0416797_A1", "Patent Type": "Patent Application", "Publication Date": "2023-12-28", "Family Info": "JP2023548477A,EP4243844A1,CN116685204A,WO2022104321A1", "Patent Title": "MODULATING ANTIMICROBIAL PEPTIDE HALF-LIFE", "Abstract": "Methods of modulating the half-life of an antimicrobial peptide are described. The method may include administering an antimicrobial peptide to an environment where the antimicrobial peptide remains active until a specified endpoint, and on or after the specified endpoint, digesting the antimicrobial peptide with a protease to thereby inactivate the antimicrobial peptide and modulate its half-life. Compositions and kits for modulating the half-life of an antimicrobial peptide are also described."}], "Sequence Information": {"SPADE ID": "SPADE_N_00147", "Peptide Name": "Enterocin Q (EntQ; Bacteriocin)", "Source": "Enterococcus faecium L50 (Gram-positive bacteria)", "Family": "Belongs to the class IId bacteriocin", "Gene": "entqA", "Sequence": "MNFLKNGIAKWMTGAELQAYKKKYGCLPWEKISC", "Sequence Length": 34, "UniProt Entry": ["http://www.uniprot.org/uniprot/Q7WYZ9"], "Protein Existence": "Predicted", "Biological Activity": ["Antimicrobial", "Antibacterial"], "Target Organism": "A broad antimicrobial spectrum against the most relevant beer-spoilage lactic acid bacteria (LAB) (i.e., Lactobacillus brevis and Pediococcus damnosus).", "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry", "Cytotoxicity": "Not included yet", "Binding Target": "Not found", "Linear/Cyclic": "Not included yet", "N-terminal Modification": "Not included yet", "C-terminal Modification": "Not included yet", "Stereochemistry": "Not included yet", "Structure Description": "Not found", "Formula": "C181H281N45O46S4", "Mass": 3951.7, "PI": 9.39, "Net Charge": 4, "Hydrophobicity": -0.36, "Half Life": "Mammalian:30 hourYeast:>20 hourE.coli:>10 hour", "Comments": "Enterococcus faecium L50 produces, in addition to EntL50, the sec-dependent pediocin-like enterocin P (EntP), and an unmodified non-pediocin-like bacteriocin, termed enterocin Q (EntQ), synthesized without an N-terminal leader sequence or signal peptide. (Ref.1)", "Literature": [{"Title": "Biochemical and genetic evidence that Enterococcus faecium L50 produces enterocins L50A and L50B, the sec-dependent enterocin P, and a novel bacteriocin secreted without an N-terminal extension termed enterocin Q.", "Pubmed ID": "11073927", "Reference": "J Bacteriol. 2000 Dec;182(23)6806-6814.", "Author": "Cintas LM, Casaus P, Herranz C, H¢varstein LS, Holo H, Hern¡ndez PE, Nes IF.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=11073927"}, {"Title": "Complete sequence of the enterocin Q-encoding plasmid pCIZ2 from the multiple bacteriocin producer Enterococcus faecium L50 and genetic characterization of enterocin Q production and immunity.", "Pubmed ID": "17021217", "Reference": "Appl Environ Microbiol. 2006 Oct;72(10)6653-6666.", "Author": "Criado R, Diep DB, Aakra A, Guti©rrez J, Nes IF, Hern¡ndez PE, Cintas LM.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=17021217"}], "Frequent Amino Acids": "KAG", "Absent Amino Acids": "DHORUV", "Basic Residues": 6, "Acidic Residues": 2, "Hydrophobic Residues": 16, "Polar Residues": 18, "Positive Residues": 6, "Negative Residues": 2, "Similar Sequences": []}}}